恒瑞医药与凯莱英凭借中国中期数据积极推动减肥药研发。
Hengrui, Kailera push obesity pill ahead on promising mid-stage China data
生物技术与制药领域的最新动态
Hengrui, Kailera push obesity pill ahead on promising mid-stage China data
Waters Corporation (WAT) Shares Fall 14.5% Following FY2026 Guidance Despite Q4 Beat - AlphaStreet News -
Thermo Fisher Scientific Prices $3.8 Billion Senior Notes - marketscreener.com
Midwest Trust Co Has $43.26 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Illumina, Inc. $ILMN Shares Sold by GUARDCAP ASSET MANAGEMENT Ltd - MarketBeat
GUARDCAP ASSET MANAGEMENT Ltd Decreases Holdings in Waters Corporation $WAT - MarketBeat
Thermo Fisher prices $3.8B note offering - MSN
Waters Corporation (WAT) Reports Strong Q4 2025 Results and Prom - GuruFocus
Thermo Fisher prices $3.8 billion notes offering for Clario acquisition - Investing.com
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - The AI Journal
Thermo Fisher Scientific Says Prices $3.8 Bln Offering Of USD-Denominated Senior Notes - TradingView
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - Yahoo Finance
Waters Corporation (WAT) Completes Strategic Merger with BD's Sp - GuruFocus
Bristol Myers and Evinova pen global development partnership
FDA rejects Regenxbio's gene therapy in Hunter syndrome, leaving CEO 'concerned'
Sex peptide targets distinct higher order processing neurons in the brain to induce the female post-mating response
Waters Corporation (NYSE:WAT) Reports Q4 CY2025 In Line With Expectations - TradingView
Waters Corporation (NYSE:WAT) Reports Q4 CY2025 In Line With Expectations - Yahoo! Finance Canada
FDA rejects Regenxbio's Hunter syndrome gene therapy
With scant data, RFK Jr. credits Trump for higher European drug prices